BANK VONTOBEL AG | Market Closed - Bid/Ask 11:20:00 2024-06-27 EDT | Pre-market 02:00:05 | |||
| 98.51 USD | -0.60% |
|
98.8 | +0.30% |
| Current month | -0.39% | ||
| 1 month | -1.39% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-27 | 98.51 | -0.60% |
| 24-06-25 | 99.1 | +0.51% |
| 24-06-24 | 98.6 | +0.92% |
| 24-06-19 | 97.7 | -1.82% |
Delayed Quote Swiss Exchange
Last update June 27, 2024 at 11:20 am
More quotesStatic data
| Product type | Bonos de Acciones |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Vontobel
|
| RMBVTV | |
| ISIN | CH1308709075 |
| Date issued | 2023-12-14 |
| Strike | 282.6 $ |
| Maturity | 2025-12-15 (536 Days) |
| Parity | 0.28 : 1 |
| Emission price | 98 $ |
| Emission volume | N/A |
| Settlement | Ambos |
| Currency | USD |
Technical Indicators
| Highest since issue | 101.5 $ |
|---|---|
| Lowest since issue | 96.6 $ |
| Spread | 8.1 $ |
| Spread % | 0.82% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
313.7
USD
Average target price
316.4
USD
Spread / Average Target
+0.88%
- Stock Market
- Certificates
- RMBVTV Certificat
